BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36997640)

  • 1. Nirogacestat effective in desmoid tumours.
    Sidaway P
    Nat Rev Clin Oncol; 2023 May; 20(5):284. PubMed ID: 36997640
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety and efficacy of gamma-secretase inhibitor nirogacestat (PF-03084014) in desmoid tumor: Report of four pediatric/young adult cases.
    Takahashi T; Prensner JR; Robson CD; Janeway KA; Weigel BJ
    Pediatr Blood Cancer; 2020 Oct; 67(10):e28636. PubMed ID: 32762028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nirogacestat: First Approval.
    Keam SJ
    Drugs; 2024 Mar; 84(3):355-361. PubMed ID: 38409573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors.
    Gounder M; Ratan R; Alcindor T; Schöffski P; van der Graaf WT; Wilky BA; Riedel RF; Lim A; Smith LM; Moody S; Attia S; Chawla S; D'Amato G; Federman N; Merriam P; Van Tine BA; Vincenzi B; Benson C; Bui NQ; Chugh R; Tinoco G; Charlson J; Dileo P; Hartner L; Lapeire L; Mazzeo F; Palmerini E; Reichardt P; Stacchiotti S; Bailey HH; Burgess MA; Cote GM; Davis LE; Deshpande H; Gelderblom H; Grignani G; Loggers E; Philip T; Pressey JG; Kummar S; Kasper B
    N Engl J Med; 2023 Mar; 388(10):898-912. PubMed ID: 36884323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NIRO or No-go? Positioning a Novel Systemic Treatment Option for Desmoid Tumours.
    Loong HH; Gupta A; Gronchi A
    Ann Surg Oncol; 2023 May; 30(5):2570-2573. PubMed ID: 36907961
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-Term Follow-Up of Desmoid Fibromatosis Treated with PF-03084014, an Oral Gamma Secretase Inhibitor.
    Villalobos VM; Hall F; Jimeno A; Gore L; Kern K; Cesari R; Huang B; Schowinsky JT; Blatchford PJ; Hoffner B; Elias A; Messersmith W
    Ann Surg Oncol; 2018 Mar; 25(3):768-775. PubMed ID: 28887726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggressive fibromatosis of the head and neck (desmoid tumours).
    Abdelkader M; Riad M; Williams A
    J Laryngol Otol; 2001 Oct; 115(10):772-6. PubMed ID: 11667985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An unusual presentation of aggressive fibromatosis (retroperitoneal desmoid tumour) in pelvic cavity presented as obstructed labour.
    Tankshali R; Srivastava S; Anshuman K; Shah M
    J Indian Med Assoc; 2011 Aug; 109(8):589-91. PubMed ID: 22315870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone regulates cell proliferation in aggressive fibromatosis (desmoid tumour).
    Hong H; Nadesan P; Poon R; Alman BA
    Br J Cancer; 2011 Apr; 104(9):1452-8. PubMed ID: 21468052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desmoid-Type Fibromatosis: Evolving Treatment Standards.
    Fiore M; MacNeill A; Gronchi A; Colombo C
    Surg Oncol Clin N Am; 2016 Oct; 25(4):803-26. PubMed ID: 27591500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and progression of a desmoid precursor lesion in patients with familial adenomatous polyposis.
    Clark SK; Smith TG; Katz DE; Reznek RH; Phillips RK
    Br J Surg; 1998 Jul; 85(7):970-3. PubMed ID: 9692575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Desmoid-type fibromatosis (aggressive fibromatosis)].
    Kuhnen C; Helwing M; Rabstein S; Homann HH; Müller KM
    Pathologe; 2005 Mar; 26(2):117-26. PubMed ID: 15657684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Infantile aggressive fibromatosis (desmoid fibromatosis)].
    Amoric JC; Fraitag S; Teillac-Hamel D; Chrétien B; De Prost Y
    Ann Dermatol Venereol; 1993; 120(11):762-3. PubMed ID: 8210103
    [No Abstract]   [Full Text] [Related]  

  • 14. Extra-abdominal desmoid fibromatosis: two familial cases with synchronous and metachronous multicentric hyalinizing nodules.
    Watanabe K; Ogura G; Tajino T; Suzuki T
    Histopathology; 2002 Aug; 41(2):118-21. PubMed ID: 12147088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current management and recent progress in desmoid tumors.
    Zhou MY; Bui NQ; Charville GW; Ghanouni P; Ganjoo KN
    Cancer Treat Res Commun; 2022; 31():100562. PubMed ID: 35460976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential diagnostic considerations of desmoid-type fibromatosis.
    Goldstein JA; Cates JM
    Adv Anat Pathol; 2015 Jul; 22(4):260-6. PubMed ID: 26050263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extra-abdominal desmoid fibromatosis: A review of management, current guidance and unanswered questions.
    Eastley N; McCulloch T; Esler C; Hennig I; Fairbairn J; Gronchi A; Ashford R
    Eur J Surg Oncol; 2016 Jul; 42(7):1071-83. PubMed ID: 26965303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infantile fibromatosis (desmoid type)--a case report.
    Desai SR; Dombale VD; Janugade HB
    Indian J Pathol Microbiol; 2005 Jul; 48(3):379-80. PubMed ID: 16761760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rare sporadic pancreatic desmoid fibromatosis diagnosed by endoscopic ultrasound-guided fine-needle aspiration: Case report and literature review.
    Stone AB; Mallery JS; Stewart J; Amin K
    Diagn Cytopathol; 2021 Feb; 49(2):E49-E54. PubMed ID: 32857922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in desmoid-type fibromatosis: a clinicopathological and immunohistochemical analysis of 46 cases.
    Huang PW; Tzen CY
    Pathology; 2010 Feb; 42(2):147-50. PubMed ID: 20085516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.